Model of the TBP-TFIIB complex from Plasmodium falciparum: interface analysis and perspectives as a new target for antimalarial design.

BACKGROUND Malaria affects 200-300 million individuals per year worldwide. Plasmodium falciparum is the causative agent of the most severe and mortal type of malaria. The need for new antimalarials comes from the widespread resistance to those in current use. New antimalarial targets are required to increase chemical diversity and effectiveness of the drugs. The research for such new targets and drug chemotypes is aided by structure-based drug design. We present a model of the TBP-TFIIB complex from P. falciparum (pfTBP-pfTFIIB) and a detailed study of the interactions at the TBP-TFIIB interface. METHODS The model was built using standard methodology, optimized energetically and evaluated structurally. We carried out an analysis of the interface considering its evolution, available experimental data on TBP and TFIIB mutants, and the main conserved and non-conserved interactions. To support the perspective of using this complex as a new target for rational antimalarial design, we present the comparison of the pfTBP-pfTFIIB interface with its human homolog. RESULTS Despite the high residue conservation at the interface, we identified a potential region, composed of species-specific residues that can be used for rational antimalarial design. CONCLUSIONS Currently there are no antimalarial drugs targeted to stop the nuclear transcription process, a vital event for all replication stages of P. falciparum. Due to its absolute requirement in transcription initiation, we consider the pfTBP-pfTFIIB interface as a new potential target for novel antimalarial chemotypes.

[1]  F. Rey,et al.  The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB. , 1996, Journal of molecular biology.

[2]  J. Cheong,et al.  Hepatitis B Virus X Protein Is a Transcriptional Modulator That Communicates with Transcription Factor IIB and the RNA Polymerase II Subunit 5* , 1997, The Journal of Biological Chemistry.

[3]  C. Cole,et al.  Efficient transcriptional activation of many simple modular promoters by simian virus 40 large T antigen , 1993, Journal of virology.

[4]  P B Sigler,et al.  The structural basis for the oriented assembly of a TBP/TFB/promoter complex. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Eisen,et al.  Why PLoS Became a Publisher , 2003, PLoS biology.

[6]  J. Reese.  Basal transcription factors. , 2003, Current opinion in genetics & development.

[7]  B. Chung,et al.  Function of steroidogenic factor 1 domains in nuclear localization, transactivation, and interaction with transcription factor TFIIB and c-Jun. , 1999, Molecular endocrinology.

[8]  G M Clore,et al.  Exploring the limits of precision and accuracy of protein structures determined by nuclear magnetic resonance spectroscopy. , 1993, Journal of molecular biology.

[9]  Alexander D. MacKerell,et al.  Development and current status of the CHARMM force field for nucleic acids , 2000, Biopolymers.

[10]  Qiang Zhou,et al.  Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-κB , 1993, Nature.

[11]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[12]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[13]  F. Joubert,et al.  Comparative properties of a three‐dimensional model of Plasmodium falciparum ornithine decarboxylase , 2003, Proteins.

[14]  C. Sander,et al.  Quality control of protein models : directional atomic contact analysis , 1993 .

[15]  J. Thornton,et al.  Stereochemical quality of protein structure coordinates , 1992, Proteins.

[16]  D. Ohlendorf,et al.  Acuracy of refined protein structures. II. Comparison of four independently refined models of human interleukin 1beta. , 1994, Acta crystallographica. Section D, Biological crystallography.

[17]  N. Kshirsagar,et al.  Vivax malaria resistant to chloroquine: case reports from Bombay. , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[18]  J. Way,et al.  Covalent modification as a strategy to block protein-protein interactions with small-molecule drugs. , 2000, Current opinion in chemical biology.

[19]  S. Burley,et al.  Crystal structure of a TFIIB–TBP–TATA-element ternary complex , 1995, Nature.

[20]  I. Wang,et al.  Interaction between the Retinoid X Receptor and Transcription Factor IIB Is Ligand-dependent in Vivo * , 1998, The Journal of Biological Chemistry.

[21]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[22]  S. Buratowski,et al.  Interdependent Interactions between TFIIB, TATA Binding Protein, and DNA , 2002, Molecular and Cellular Biology.

[23]  N. Ben-Tal,et al.  ConSurf: an algorithmic tool for the identification of functional regions in proteins by surface mapping of phylogenetic information. , 2001, Journal of molecular biology.

[24]  S. Roberts,et al.  The conformation of the transcription factor TFIIB modulates the response to transcriptional activators in vivo , 2000, Current Biology.

[25]  P B Sigler,et al.  The 2.1-A crystal structure of an archaeal preinitiation complex: TATA-box-binding protein/transcription factor (II)B core/TATA-box. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  G Vriend,et al.  WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.

[27]  R. Gwilliam,et al.  Sequence of Plasmodium falciparum chromosomes 1, 3–9 and 13 , 2002, Nature.

[28]  F. Jørgensen,et al.  Towards an understanding of drug resistance in malaria: three-dimensional structure of Plasmodium falciparum dihydrofolate reductase by homology building. , 1999, Bioorganic & medicinal chemistry.

[29]  S. Hoffman,et al.  Vivax malaria resistant to treatment and prophylaxis with chloroquine , 1993, The Lancet.

[30]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[31]  Roger D Kornberg,et al.  Structural Basis of Transcription: An RNA Polymerase II-TFIIB Cocrystal at 4.5 Angstroms , 2004, Science.

[32]  T. Kodadek,et al.  Biochemical Characterization of the TATA-binding Protein-Gal4 Activation Domain Complex* , 2000, The Journal of Biological Chemistry.

[33]  Michael R. Green,et al.  Activator-induced conformational change in general transcription factor TFIIB , 1994, Nature.

[34]  S. Krishna,et al.  Artemisinins target the SERCA of Plasmodium falciparum , 2003, Nature.

[35]  C. Colangelo,et al.  The N-terminal domain of TFIIB from Pyrococcus furiosus forms a zinc ribbon , 1996, Nature Structural Biology.

[36]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[37]  O. Jardetzky,et al.  An assessment of the precision and accuracy of protein structures determined by NMR. Dependence on distance errors. , 1994, Journal of molecular biology.

[38]  Myint-Oo,et al.  Development of resistance to chloroquine by Plasmodium vivax in Myanmar. , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[39]  R. Roeder,et al.  TATA-binding Protein Residues Implicated in a Functional Interplay between Negative Cofactor NC2 (Dr1) and General Factors TFIIA and TFIIB (*) , 1995, The Journal of Biological Chemistry.

[40]  A. Cochran,et al.  Protein-protein interfaces: mimics and inhibitors. , 2001, Current opinion in chemical biology.

[41]  L. Cong,et al.  Artemisinin kinetics and dynamics during oral and rectal treatment of uncomplicated malaria , 1998, Clinical pharmacology and therapeutics.

[42]  B. Pugh,et al.  Control of gene expression through regulation of the TATA-binding protein. , 2000, Gene.

[43]  K. Sharp,et al.  Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.

[44]  P. Carlsson,et al.  The Human Forkhead Protein FREAC-2 Contains Two Functionally Redundant Activation Domains and Interacts with TBP and TFIIB* , 1998, The Journal of Biological Chemistry.

[45]  I. Haviv,et al.  Hepatitis B Virus pX Targets TFIIB in Transcription Coactivation , 1998, Molecular and Cellular Biology.

[46]  K. Struhl,et al.  A severely defective TATA-binding protein-TFIIB interaction does not preclude transcriptional activation in vivo , 1997, Molecular and cellular biology.

[47]  D. Eisenberg,et al.  Computational methods of analysis of protein-protein interactions. , 2003, Current opinion in structural biology.

[48]  John P. Overington,et al.  Derivation of rules for comparative protein modeling from a database of protein structure alignments , 1994, Protein science : a publication of the Protein Society.

[49]  J. Derisi,et al.  The Transcriptome of the Intraerythrocytic Developmental Cycle of Plasmodium falciparum , 2003, PLoS biology.

[50]  P. Olliaro,et al.  Mode of action and mechanisms of resistance for antimalarial drugs. , 2001, Pharmacology & therapeutics.

[51]  M. Green,et al.  In vitro interaction of the human immunodeficiency virus type 1 Tat transactivator and the general transcription factor TFIIB with the cellular protein TAP , 1995, Journal of virology.

[52]  Andrej ⩽ali,et al.  Comparative protein modeling by satisfaction of spatial restraints , 1995 .

[53]  J. E. Hyde,et al.  Characterisation of the gene encoding an unusually divergent TATA-binding protein (TBP) from the extremely A+T-rich human malaria parasite Plasmodium falciparum. , 1993, Gene.

[54]  B. Raaka,et al.  A 10-amino-acid sequence in the N-terminal A/B domain of thyroid hormone receptor alpha is essential for transcriptional activation and interaction with the general transcription factor TFIIB , 1995, Molecular and cellular biology.

[55]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[56]  J. D. Benson,et al.  Conserved interaction of the papillomavirus E2 transcriptional activator proteins with human and yeast TFIIB proteins , 1997, Journal of virology.

[57]  J. Svejstrup,et al.  The NC2 alpha and beta subunits play different roles in vivo. , 2002, Genes & development.

[58]  W. Herr,et al.  Selective Use of TBP and TFIIB Revealed by a TATA-TBP-TFIIB Array with Altered Specificity , 1997, Science.

[59]  Itay Mayrose,et al.  Rate4Site: an algorithmic tool for the identification of functional regions in proteins by surface mapping of evolutionary determinants within their homologues , 2002, ISMB.

[60]  R. Huber,et al.  Accurate Bond and Angle Parameters for X-ray Protein Structure Refinement , 1991 .

[61]  R. V. Huijsduijnen.  Protein tyrosine phosphatases: counting the trees in the forest , 1998 .

[62]  S Vajda,et al.  Dynamical view of the positions of key side chains in protein-protein recognition. , 2001, Biophysical journal.

[63]  C. Ingles,et al.  Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID , 1990, Nature.

[64]  Suradi,et al.  Survey of resistance in vivo to chloroquine of Plasmodium falciparum and P. vivax in North Sulawesi, Indonesia. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[65]  R. Albrecht,et al.  Interaction of the Equine Herpesvirus 1 EICP0 Protein with the Immediate-Early (IE) Protein, TFIIB, and TBP May Mediate the Antagonism between the IE and EICP0 Proteins , 2003, Journal of Virology.

[66]  P. Sigler,et al.  Structural basis of preinitiation complex assembly on human Pol II promoters , 2000, The EMBO journal.

[67]  Michael R. Green,et al.  Promoter-specific activation defects by a novel yeast TBP mutant compromised for TFIIB interaction , 2001, Current Biology.

[68]  K. Rieckmann,et al.  PLASMODIUM VIVAX RESISTANCE TO CHLOROQUINE? , 1989, The Lancet.

[69]  R. Kobayashi,et al.  A basal transcription factor that activates or represses transcription. , 2000, Science.

[70]  Jonathan E. Allen,et al.  Genome sequence of the human malaria parasite Plasmodium falciparum , 2002, Nature.

[71]  Bernhard Lüscher,et al.  Characterization of the Transcriptional Regulator YY1 , 1997, The Journal of Biological Chemistry.

[72]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[73]  P. Jalinot,et al.  Biochemical and functional interaction of the human immunodeficiency virus type 1 Tat transactivator with the general transcription factor TFIIB. , 1997, The Journal of general virology.

[74]  W. Gurley,et al.  Role of the TATA Binding Protein–Transcription Factor IIB Interaction in Supporting Basal and Activated Transcription in Plant Cells , 2000, Plant Cell.

[75]  K. Rieckmann,et al.  Chloroquine-resistant Plasmodium vivax in Papua New Guinea. , 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[76]  M. Ikura,et al.  FRET evidence for a conformational change in TFIIB upon TBP-DNA binding. , 2004, European journal of biochemistry.

[77]  J. Omichinski,et al.  Structure of a (Cys3His) zinc ribbon, a ubiquitous motif in archaeal and eucaryal transcription , 2000, Protein science : a publication of the Protein Society.

[78]  Rakitzis Et,et al.  ENZYME-STRIP ESTIMATION OF BLOOD-GLUCOSE. , 1964 .

[79]  M. Haussler,et al.  Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[80]  G. Nabel,et al.  Specificity of Cyclin E-Cdk2, TFIIB, and E1A Interactions with a Common Domain of the p300 Coactivator , 1999, Molecular and Cellular Biology.

[81]  A. Emili,et al.  Characterization of the interaction between the acidic activation domain of VP16 and the RNA polymerase II initiation factor TFIIB. , 1996, Nucleic acids research.

[82]  J. Thorner,et al.  High Affinity Interaction of Yeast Transcriptional Regulator, Mot1, with TATA Box-binding Protein (TBP)* , 2001, The Journal of Biological Chemistry.

[83]  R. Young,et al.  Regulation of gene expression by TBP-associated proteins. , 1998, Genes & development.

[84]  A. Sali,et al.  Modeling of loops in protein structures , 2000, Protein science : a publication of the Protein Society.